Skip to main content

HeartSciences Inc.

HSCS
Exchange
Nasdaq
Industry
Finance Services
SEC CIK
0001468492

No open-market purchases or sales by HeartSciences Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $385.8K in total; no superinvestor holds it.

Other share classesHSCSW

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +3 vs. previous quarter
16
13F valueReported value at the end of Q2 2026
$385.8K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding HSCS, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding HSCS at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by HeartSciences Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 30, 2025 (view filing)Jul 291 dayHilz Mark TCOO, Secretary and DirectorSSaleCommon Stock, $0.001 par value−4.42K$3.54−$15.6K−48.2%4.75K after

Top 10 13F holders, Q2 2026

The largest institutional positions in HeartSciences Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 16 holders
Institutions holding HSCS in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
TFB Advisors LLC29,740$74.6K0.03%00.0%Unchanged
Geode Capital Management, LLC23,049$57.9K0.00%−5,889−20.4%Reduced
Astoria Strategic Wealth, Inc.18,927$47.5K0.01%00.0%Unchanged
Vanguard Capital Management LLC17,968$45.1K0.00%00.0%Unchanged
Vanguard Fiduciary Trust Co17,239$43.3K0.00%00.0%Unchanged
Tradition Wealth Management, LLC16,819$42.2K0.00%00.0%Unchanged
Citadel Advisors LLC14,488$36.4K0.00%+14,488New
Citigroup Inc5,859$14.7K0.00%+5,859New
UBS Group AG5,812$14.6K0.00%−664−10.3%Reduced
Tower Research Capital LLC (TRC)1,568$3.94K0.00%−483−23.5%Reduced